DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED
Clinical trials for DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED trials appear
Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug lorlatinib tested in kids with rare brain tumors
Disease control Recruiting nowThis early-phase study tests the drug lorlatinib in children and young adults (ages 1 to 21) with newly diagnosed high-grade glioma, a fast-growing brain tumor, that has a specific genetic change (ALK or ROS1 fusion). The goal is to see if the drug can shrink or control the tumor…
Matched conditions: DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED
Phase: EARLY_PHASE1 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for kids with deadly brain cancer? drug ONC206 enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug called ONC206 in children and young adults with diffuse midline glioma or other recurrent brain tumors. The drug aims to kill cancer cells by causing stress in them, without harming healthy cells. Researchers are looking for the safest dose…
Matched conditions: DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED
Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for kids with DIPG: major trial compares two treatments
Disease control Recruiting nowThis phase 3 trial tests whether the drug ONC201 works better than everolimus for children and adults with DIPG, a rare and aggressive brain tumor. About 433 participants will receive one of the two drugs, and can switch if their disease gets worse. The goal is to see which drug …
Matched conditions: DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC